Five MD Anderson researchers elected AAAS Fellows
In recognition of their achievements in advancing cancer research, five faculty members from The University of Texas MD Anderson Cancer Center have been named fellows of the American Association for the Advancement of Science (AAAS). AAAS Fellows are elected by their peers, a tradition that began in 1874, in honor of their invaluable contributions to science and technology. MD Anderson’s faculty now includes 49 AAAS...
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical...
MD Anderson joins thousands of top U.S. hospitals encouraging everyone to #MaskUp
The University of Texas MD Anderson Cancer Center and more than 100 of the nation’s top health care systems, representing thousands of hospitals...
A Conversation With a Living Legend honoring Admiral William H. McRaven raises $1 million
The North Texas A Conversation With a Living Legend® raised $1 million this week in a virtual version of the signature fundraising event benefiting The University of Texas MD Anderson Cancer Center. The 31st annual event honored Admiral William H. McRaven, U.S. Navy, Retired, in an interview Nov. 16 with CBS News' Bob Schieffer. Proceeds will benefit MD Anderson’s Moon Shots Program®, a collaborative effort to accelerate the development...
MD Anderson and Obsidian Therapeutics announce strategic collaboration to accelerate advancement of novel engineered tumor infiltrating lymphocyte therapy (cytoTIL™) for solid tumors
The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced a multi-year strategic collaboration designed...
Sherry Adkins receives Brown Foundation Award for Excellence in Oncology Nursing
Sherry Adkins is the recipient of the 2020 Brown Foundation Award for Excellence in Oncology Nursing at The University of Texas MD Anderson...
MD Anderson announces fifth annual class of Andrew Sabin Family Fellows
The University of Texas MD Anderson Cancer Center has named 10 early-career faculty members to the 2020 class of Andrew Sabin Family Fellows...
MD Anderson researchers present immunotherapy advances at Society for Immunotherapy of Cancer Annual Meeting
ABSTRACTS 277, 368, 420
Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight...
Large-scale cancer proteomics study profiles protein changes in response to drug treatments
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas...
MD Anderson and UT Austin collaboration to end cancer welcomed enthusiastically by state and federal stakeholders
A new collaboration combining cancer research with advanced computing and computational modeling techniques received strong engagement and...